5/11
11:41 am
vktx
3 Monster Stocks in the Making [Yahoo! Finance]
Low
Report
3 Monster Stocks in the Making [Yahoo! Finance]
5/4
01:19 am
vktx
Why Viking Therapeutics Stock Was Victorious This Week [Yahoo! Finance]
Low
Report
Why Viking Therapeutics Stock Was Victorious This Week [Yahoo! Finance]
5/2
02:33 pm
vktx
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 [Yahoo! Finance]
Low
Report
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 [Yahoo! Finance]
5/2
04:27 am
vktx
Where Will Viking Therapeutics Be in 3 Years? [Yahoo! Finance]
Low
Report
Where Will Viking Therapeutics Be in 3 Years? [Yahoo! Finance]
5/1
06:06 am
vktx
1 Beaten-Down Stock to Buy and Hold for 10 Years [Yahoo! Finance]
Low
Report
1 Beaten-Down Stock to Buy and Hold for 10 Years [Yahoo! Finance]
5/1
12:12 am
vktx
Why Viking Therapeutics Stock Popped Again Today [Yahoo! Finance]
Low
Report
Why Viking Therapeutics Stock Popped Again Today [Yahoo! Finance]
4/30
07:41 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
4/28
05:16 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $104.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $104.00 price target on the stock.
4/28
11:16 am
vktx
Why Viking Therapeutics Stock Popped Today [Yahoo! Finance]
Medium
Report
Why Viking Therapeutics Stock Popped Today [Yahoo! Finance]
4/28
10:13 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $75.00 price target on the stock, down previously from $95.00.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $75.00 price target on the stock, down previously from $95.00.
4/24
01:12 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Morgan Stanley from $105.00 to $102.00. They now have an "overweight" rating on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Morgan Stanley from $105.00 to $102.00. They now have an "overweight" rating on the stock.
4/24
08:15 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
4/23
04:05 pm
vktx
Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Low
Report
Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
4/21
09:19 am
vktx
Viking Therapeutics to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]
Low
Report
Viking Therapeutics to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]
4/18
02:00 pm
vktx
Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735 [Yahoo! Finance]
Low
Report
Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735 [Yahoo! Finance]
4/18
12:02 pm
vktx
H.C. Wainwright still expects Viking to ‘differentiate' after Lilly data [Yahoo! Finance]
Low
Report
H.C. Wainwright still expects Viking to ‘differentiate' after Lilly data [Yahoo! Finance]
4/17
01:31 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
4/17
10:11 am
vktx
2 Stocks Down by 25% or More This Year to Buy and Hold [Yahoo! Finance]
Medium
Report
2 Stocks Down by 25% or More This Year to Buy and Hold [Yahoo! Finance]
4/16
04:20 pm
vktx
Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025 [Yahoo! Finance]
Low
Report
Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025 [Yahoo! Finance]
4/16
04:05 pm
vktx
Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025
Low
Report
Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025
4/15
10:29 am
vktx
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock? [Yahoo! Finance]
Low
Report
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock? [Yahoo! Finance]
4/8
10:07 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $30.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $30.00 price target on the stock.
4/4
10:24 am
vktx
The Smartest Biotech Stocks to Buy With $50 [Yahoo! Finance]
Medium
Report
The Smartest Biotech Stocks to Buy With $50 [Yahoo! Finance]
4/1
08:12 pm
vktx
Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]
Medium
Report
Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]
3/31
11:43 pm
vktx
Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month [Yahoo! Finance]
Low
Report
Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month [Yahoo! Finance]